CVS Group (LON:CVSG) Full Year 2024 Results
Key Financial Results
- Revenue: UK£647.3m (up 6.4% from FY 2023).
- Net income: UK£26.2m (down 38% from FY 2023).
- Profit margin: 4.0% (down from 6.9% in FY 2023). The decrease in margin was driven by higher expenses.
- EPS: UK£0.36 (down from UK£0.59 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
CVS Group Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) also missed analyst estimates by 84%.
Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the United Kingdom.
Performance of the British Healthcare industry.
The company's shares are down 1.5% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 2 warning signs for CVS Group you should be aware of.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About AIM:CVSG
CVS Group
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
Good value with reasonable growth potential.